92 related articles for article (PubMed ID: 30531476)
1. QTc Prolongation Associated With Psychiatric Medications: A Retrospective Cross-Sectional Study of Adult Inpatients.
Shao W; Ayub S; Drutel R; Heise WC; Gerkin R
J Clin Psychopharmacol; 2019; 39(1):72-77. PubMed ID: 30531476
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients.
Al-Azayzih A; Al-Qerem W; Al-Azzam S; Muflih S; Al-Husein BA; Kharaba Z; Kanaan RJ; Rahhal D
Vasc Health Risk Manag; 2024; 20():27-37. PubMed ID: 38318252
[TBL] [Abstract][Full Text] [Related]
3. The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department.
Cole JB; Lee SC; Martel ML; Smith SW; Biros MH; Miner JR
West J Emerg Med; 2020 Jul; 21(4):728-736. PubMed ID: 32726229
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study.
Yuan N; Oesterle A; Botting P; Chugh S; Albert C; Ebinger J; Ouyang D
JMIR Cardio; 2023 Jan; 7():e41055. PubMed ID: 36662566
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study.
Ali Z; Ismail M; Nazar Z; Khan F; Khan Q; Noor S
BMC Psychiatry; 2020 Jun; 20(1):277. PubMed ID: 32493330
[TBL] [Abstract][Full Text] [Related]
6. Personalized, intuitive & visual QT-prolongation monitoring using patient-specific QTc threshold with pseudo-coloring and explainable AI.
Alahmadi A; Davies A; Vigo M; Jay C
J Electrocardiol; 2023; 81():218-223. PubMed ID: 37837739
[TBL] [Abstract][Full Text] [Related]
7. Incidences, risk factors, and clinical correlates of severe QT prolongation after the use of quetiapine or haloperidol.
Wang CL; Wu VC; Lee CH; Wu CL; Chen HM; Huang YT; Chang SH
Heart Rhythm; 2024 Mar; 21(3):321-328. PubMed ID: 38231170
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the prescribing and monitoring of medications associated with QTc-prolongation in the ambulatory care setting.
Lowe RN; Wright G; Olivas L; Teel C; Suresh K; Macke LB; Sieja A; Rosenberg MA; Trinkley KE
J Eval Clin Pract; 2024 Apr; 30(3):385-392. PubMed ID: 38073034
[TBL] [Abstract][Full Text] [Related]
9. The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients.
Fan W; Liu H; Shen Y; Hong K
Cardiovasc Drugs Ther; 2024 Jun; 38(3):517-525. PubMed ID: 36625987
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with prolonged QTc interval in Iranian population: MASHAD cohort study.
Sahranavard T; Soflaei SS; Alimi R; Pourali G; Nasrabadi M; Yadollahi A; Sharifi S; Alimi H; Shahri B; Ghalibaf AM; Metanat S; Ferns GA; Moohebati M; Ghayour-Mobarhan M
J Electrocardiol; 2024; 84():112-122. PubMed ID: 38631278
[TBL] [Abstract][Full Text] [Related]
11. Comparison of QTc interval changes in drug-resistant tuberculosis patients on delamanid-containing regimens versus shorter treatment regimens.
Jefman Efendi Marzuki HY; Nafrialdi N; Sawitri N; Sugiri YJ; Gusti Agung Ayu Putu Sri Darmayani I; Ascobat P
Int J Risk Saf Med; 2024; 35(2):181-190. PubMed ID: 38701163
[TBL] [Abstract][Full Text] [Related]
12. A smart algorithm for the prevention and risk management of QTc prolongation based on the optimized RISQ-PATH model.
Vandael E; Vandenberk B; Vandenberghe J; Van den Bosch B; Willems R; Foulon V
Br J Clin Pharmacol; 2018 Dec; 84(12):2824-2835. PubMed ID: 30112769
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors of prolonged corrected QT interval in general Chinese population.
Ma Q; Li Z; Guo X; Guo L; Yu S; Yang H; Zou L; Zheng L; Pan G; Zhang Y; Sun Y
BMC Cardiovasc Disord; 2019 Nov; 19(1):276. PubMed ID: 31783793
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia.
Sankaranarayanan A; Kazi S; Andrade C
Schizophr Res; 2024 Jun; 268():145-149. PubMed ID: 37770378
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent QTc interval prolongation under haloperidol and pipamperone in the management of delirium in a naturalistic setting.
Bohny P; Boettger S; Jenewein J
Front Psychiatry; 2023; 14():1257755. PubMed ID: 37854439
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports.
Hasnain M; Vieweg WV; Howland RH; Kogut C; Breden Crouse EL; Koneru JN; Hancox JC; Digby GC; Baranchuk A; Deshmukh A; Pandurangi AK
Ther Adv Psychopharmacol; 2014 Jun; 4(3):130-8. PubMed ID: 25057346
[TBL] [Abstract][Full Text] [Related]
17. Population Prevalence and Correlates of Prolonged QT Interval: Cross-Sectional, Population-Based Study From Rural Uganda.
Magodoro IM; Albano AJ; Muthalaly R; Koplan B; North CM; Vořechovská D; Downey J; Kraemer J; Vaglio M; Badilini F; Kakuhire B; Tsai AC; Siedner MJ
Glob Heart; 2019 Mar; 14(1):17-25.e4. PubMed ID: 30584028
[TBL] [Abstract][Full Text] [Related]
18. High-dose benzodiazepine use and QTc interval prolongation, a latent class analysis study.
Zamboni L; Portoghese I; Casari R; Fusina F; Santin L; Lecca LI; Campagnari S; Carli S; Zandonai T; Lugoboni F
Sci Rep; 2024 Jan; 14(1):155. PubMed ID: 38168538
[TBL] [Abstract][Full Text] [Related]
19. QTc prolongation in patients with schizophrenia taking antipsychotics: Prevalence and risk factors.
Du W; Ge MW; Hu FH; Jia YJ; Zhao DY; Cheng YJ; Chen HL
J Psychopharmacol; 2023 Oct; 37(10):971-981. PubMed ID: 37534722
[TBL] [Abstract][Full Text] [Related]
20. Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports.
Vieweg WV; Hancox JC; Hasnain M; Koneru JN; Gysel M; Baranchuk A
Ther Adv Infect Dis; 2013 Aug; 1(4):121-38. PubMed ID: 25165548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
